● Recruiting

A Study to Evaluate AHB-137 Injection in Treatment-naïve Participants With Chronic Hepatitis B

Condition: Chronic Hepatitis B · Sponsor: Ausper Biopharma Co., Ltd.

PhasePhase 2

Planned participants320

Who can joinAll sexes, 18 Years to 65 Years

Healthy volunteersNo

About this study

This study is a randomized, double-blind, placebo-controlled, multicenter phase 2 study to assess the efficacy and safety of AHB-137 injection in treatment-naïve participants with chronic hepatitis B.

This description comes directly from the study's public registry record.

Talk to the study team

Lu · 0571-86959519 · clinicaltrial@ausperbio.com

Always discuss trial participation with your own doctor first.

Locations (34)

AusperBio Investigational Site	Beijing, Beijing Municipality, China	Recruiting
AusperBio Investigational Site	Chongqing, Chongqing Municipality, China	Recruiting
The Second Affiliated Hospital of Chongqing Medical University	Chongqing, Chongqing Municipality, China	Recruiting
AusperBio Investigational Site	Xiamen, Fujian, China	Recruiting
AusperBio Investigational Site	Guangzhou, Guangdong, China	Recruiting
AusperBio Investigational Site	Guangzhou, Guangdong, China	Recruiting
AusperBio Investigational Site	Guangzhou, Guangdong, China	Recruiting
AusperBio Investigational Site	Jiangmen, Guangdong, China	Recruiting
AusperBio Investigational Site	Meizhou, Guangdong, China	Recruiting
AusperBio Investigational Site	Qingyuan, Guangdong, China	Recruiting
AusperBio Investigational Site	Shenzhen, Guangdong, China	Recruiting
AusperBio Investigational Site	Shenzhen, Guangdong, China	Recruiting

+ 22 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07635186